ELEmilie Lesaine

Emilie Lesaine

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Emilie Lesaine has a total of 518 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Impact of social deprivation on access to care delay in patients with acute myocardial infarction: a French registry-based study

    by Emilie Lesaine, Sahal Miganeh-Hadi, Sandrine Domecq, Mathilde Borg, Catherine Pradeau, Pierre Coste, Florence Saillour-Glénisson, Laura Cetran

  • Optimizing prehospital ST-segment elevation myocardial infarction pathways, medical dispatch types and acute management times: A French regional registry study

    by Emilie Lesaine, Sahal Miganeh-Hadi, Mathilde Borg, Laura Cetran, Florence Saillour-Glénisson, Catherine Pradeau

  • Socio-geographical factors associated with cardiac rehabilitation participation after percutaneous coronary intervention: a registry-based cohort study from France

    by Filippo Quattrone, Emilie Lesaine, Sandrine Domecq, Jean-Pierre Legrand, Sahal Miganeh Hadi, Pierre Coste, Thierry Couffinhal, Florence Saillour Glenisson, Fournier Pierre, Jarnier Philippe, et al.

    Aims: Cardiac rehabilitation (CR) after percutaneous coronary intervention (PCI) for acute (ACS) or chronic (CCS) coronary syndrome is underutilized worldwide. The determinants of underuse are not fully understood. Using real-world data, this study explored the effect of socio-geographical factors on CR participation. Methods and results: Patients from the Aquitaine region (France) who underwent PCI between 2017 and 2019 were selected from a regional PCI register. Their 1-year CR participation was tracked using the French hospital database. Associations between CR participation and socio-geographical factors (social deprivation, general practitioner accessibility, and distance to the nearest CR centre) were assessed through logistic regression mixed models at 1 and 3 months in ACS, and at 3 and 6 months in CCS. Among the 19 002 patients, 5073 (26.7%) participated in CR (ACS: 4071, 33.0%; CCS: 1002, 15.0%). A CR centre distance >25 km reduced participation at 3 months in ACS patients [odds ratio (OR) = 0.83, 95% confidence interval (CI): 0.70–0.99, P = 0023] but not at 1 month after PCI. Chronic coronary syndrome patients from most advantaged areas were more likely to participate in CR at 3 (OR = 0.62, 95% CI: 0.44–0.88, P = 0.002) and 6 months (OR = 0.59, 95% CI: 0.42–0.82, P < 0.001). General practitioner accessibility did not affect participation. Conclusion: Post-PCI CR participation was low. Proximity to CR centres promoted participation for ACS patients, while CR usage correlated with higher socioeconomic status for CCS patients. These findings highlight socio-geographical inequalities in CR access, providing a basis for targeted interventions, such as telerehabilitation or expanded coverage.


  • Open Access

    Social and clinical vulnerability in stroke and STEMI management during the COVID-19 pandemic: a registry-based study

    by Emilie Lesaine, Florence Francis, Sandrine Domecq, Sahal Miganeh-Hadi, Floriane Sevin, Igor Sibon, François Rouanet, Catherine Pradeau, Pierre Coste, Laura Cetran, et al.

    Objective This study aims to evaluate whether the first wave of the COVID-19 pandemic resulted in a deterioration in the quality of care for socially and/or clinically vulnerable stroke and ST-segment elevation myocardial infarction (STEMI) patients. Design Two cohorts of STEMI and stroke patients in the Aquitaine neurocardiovascular registry. Setting Six emergency medical services, 30 emergency units, 14 hospitalisation units and 11 catheterisation laboratories in the Aquitaine region in France. Participants This study involved 9218 patients (6436 stroke and 2782 STEMI patients) in the neurocardiovascular registry from January 2019 to August 2020. Primary outcome measures Care management times in both cohorts: first medical contact-to-procedure time for the STEMI cohort and emergency unit admission-to-imaging time for the stroke cohort. Associations between social (deprivation index) and clinical (age >65 years, neurocardiovascular history) vulnerabilities and care management times were analysed using multivariate linear mixed models, with an interaction on the time period (pre-wave, per-wave and post-first COVID-19 wave). Results The first medical contact procedure time was longer for elderly (pConclusions This study revealed pre-existing inequalities in care management times for vulnerable STEMI and stroke patients; however, these inequalities were neither accentuated nor reduced during the first COVID-19 wave. Measures implemented during the crisis did not alter the structured emergency pathway for these patients. Trial registration number NCT04979208


  • Open Access

    Effects of healthcare system transformations spurred by the COVID-19 pandemic on management of stroke and STEMI: a registry-based cohort study in France

    by Emilie Lesaine, Florence Francis-Oliviero, Sandrine Domecq, Marine Bijon, Laura Cetran, Pierre Coste, Quentin Lhuaire, Sahal Miganeh-Hadi, Catherine Pradeau, François Rouanet, et al.

    Objective To assess the impact of changes in use of care and implementation of hospital reorganisations spurred by the COVID-19 pandemic (first wave) on the acute management times of patients who had a stroke and ST-segment elevation myocardial infarction (STEMI). Design Two cohorts of patients who had an STEMI and stroke in the Aquitaine Cardio-Neuro-Vascular (CNV) registry. Setting 6 emergency medical services, 30 emergency units (EUs), 14 hospitalisation units and 11 cathlabs in the Aquitaine region. Participants This study involved 9218 patients (6436 patients who had a stroke and 2782 patients who had an STEMI) in the CNV Registry from January 2019 to August 2020. Method Hospital reorganisations, retrieved in a scoping review, were collected from heads of hospital departments. Other data were from the CNV Registry. Associations between reorganisations, use of care and care management times were analysed using multivariate linear regression mixed models. Interaction terms between use-of-care variables and period (pre-wave, per-wave and post-wave) were introduced. Main outcome measures STEMI cohort, first medical contact-to-procedure time; stroke cohort, EU admission-to-imaging time. Results Per-wave period management times deteriorated for stroke but were maintained for STEMI. Per-wave changes in use of care did not affect STEMI management. No association was found between reorganisations and stroke management times. In the STEMI cohort, the implementation of systematic testing at admission was associated with a 41% increase in care management time (exp=1.409, 95% CI 1.075 to 1.848, p=0.013). Implementation of plan blanc, which concentrated resources in emergency activities, was associated with a 19% decrease in management time (exp=0.801, 95% CI 0.639 to 1.023, p=0.077). Conclusions The pandemic did not markedly alter the functioning of the emergency network. Although stroke patient management deteriorated, the resilience of the STEMI pathway was linked to its stronger structuring. Transversal reorganisations, aiming at concentrating resources on emergency care, contributed to maintenance of the quality of care. Trial registration number NCT04979208.


  • Top Cited Papers

    Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

    by Raul G. Nogueira, Muhammad M. Qureshi, Mohamad Abdalkader, Sheila Ouriques Martins, Hiroshi Yamagami, Zhongming Qiu, Ossama Yassin Mansour, Anvitha Sathya, Anna Czlonkowska, Georgios Tsivgoulis, et al.

    Objective To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. Methods We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. Results There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] −11.7 to −11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI −13.8 to −12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI −13.7 to −10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2–9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. Conclusions The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months.


  • Open Access

    The Impact of the Healthcare System Transformations Spurred by the COVID-19 Pandemic on Stroke and STEMI Management: Cohorts of Patients Included in a French Regional Cardio-Neuro-Vascular Registry

    by Emilie Lesaine, Florence Francis, Sandrine Domecq, Marine Bijon, Laura Cetran, Pierre Coste, Quentin Lhuaire, Sahal Miganeh-Hadi, Catherine Pradeau, Francois Rouanet, et al.

    Background Around the world, the consequences of the COVID-19 pandemic on the management of no-Covid-19 pathologies are causing concerns. We aimed to assess the impact of changes in use of care and health reorganizations implementation spurred by the COVID-19 pandemic on acute management times of strokes and ST-segment elevation myocardial infarction (STEMI).Methods Two cohorts of stroke and STEMI patients included between January 2019 and August 2020 in a French regional registry. The hospital reorganizations were collected from heads of hospital departments. The associations between reorganizations, use of care, and care management times were analyzed through multivariate linear regression mixed models. Interaction terms between the use of care variables and the period (pre, per, post-wave) were introduced.Findings A total of 9,218 patients were included (6,436 stroke and 2,782 STEMI patients). During the per-wave period, management times deteriorated for stroke but improved for STEMI. No association was found, either between use of care and care management times in both cohorts, or between reorganizations and stroke management times. In the STEMI cohort, the implementation of a systematic testing at admission was associated with an increase of 41% in care management times (exp=1·409, 95%CI [1·075-1·848], p=0·013) and an emergency unit (EU) plan was associated with a decrease of 19% in the management times (exp=0·801, 95%CI [0·639-1·023], p=0·077).Interpretation The STEMI pathway showed better resilience to the COVID-19 pandemic. Reorganizations aiming at concentrate resources in EU improved acute management of patients involved in STEMI pathway characterised by its strongest structuration. Funding: “Alliance Tous unis contre le virus” (“Fondation de France”, “AP-HP”, “Institut Pasteur”), “Nouvelle-Aquitaine Regional Health Agency”. Declaration of Interest: None to declare. Ethical Approval: The CNV registry have been approved by the French authority on data protection (CNIL) and met regulatory requirements for patient information.

  • Open Access

    Post-stroke pathway analysis and link with one year sequelae in a French cohort of stroke patients: the PAPASePA protocol study

    by S. Broussy, F. Rouanet, E. Lesaine, S. Domecq, M. Kret, M. Maugeais, F. Aly, P. Dehail, A. Bénard, J. Wittwer, et al.

    Background: Stroke is a health problem with serious consequences, both in terms of mortality, and after-effects affecting patient quality of life. Stroke requires both urgent and chronic management involving the entire health care system. Although large variability in the management of stroke patients have been noticed, knowledge of the diversity and the scalability of post-stroke pathways, whether it is the care pathway or the life pathway, is currently not sufficient. Moreover the link between post-stroke pathways and patients sequelae have not been yet clearly defined. All this information would be useful to better target the needs to improve stroke patient management. The purposes are to identify the post-stroke life pathways components associated with sequelae (activity limitations – main purpose, cognitive disorders, anxio-depressive disorders, fatigue, participation restrictions) at 3 months and 1 year post-stroke, to define a typology of life pathways of patients during the post-stroke year and to analyze the social and geographical inequalities in the management of stroke. Methods: Design: a prospective multicenter comparative cohort study with a follow up to 1 year after the acute episode. Participant centers: 13 hospitals in the Aquitaine region (France). Study population: patients diagnosed with a confirmed ischemic or hemorrhagic stroke included in the Aquitaine Observatory of Stroke (ObA2) cohort and voluntary to participate. Data sources are existing databases (ObA2 database and the French National Health Data System - SNDS) to collect information about care pathways, patient characteristics and stroke characteristics and Ad hoc surveys to collect information about life pathways and post-stroke sequelae. The endpoints of the study are post-stroke activity limitations evaluated by the modified Rankin score, other post-stroke sequelae (Cognitive disorders, anxio-depressive disorders, fatigue, restriction of participation) assessed by standardized and validated scales and Clusters of patients responding to pathways with common or similar characteristics.; Discussion: By integrating a longitudinal dimension and relying on a large cohort, the project will make it possible to identify the sources of disturbances and the factors favorable to the outcome of the life pathways, important for the planning of the offer and the management of the public policies concerning stroke pathways. Trial registration: ClinicalTrials.gov ID: NCT03865173, March 6th, 2019.